Fox Run Management, L.L.C. Alkermes Plc. Transaction History

Fox Run Management, L.L.C.

  • $553 Million
  • Q2 2025

A detailed history of Fox Run Management, L.L.C. transactions in Alkermes Plc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 14,521 shares of ALKS stock, worth $457,556. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,521
Previous 33,728 56.95%
Holding current value
$457,556
Previous $1.11 Million 62.71%
% of portfolio
0.07%
Previous 0.18%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025
SELL
$26.59 - $32.65 $510,714 - $627,108
-19,207 Reduced 56.95%
14,521 $415,000
Q1 2025

May 13, 2025
SELL
$28.08 - $36.0 $930,402 - $1.19 Million
-33,134 Reduced 49.56%
33,728 $1.11 Million
Q4 2024

Feb 11, 2025
BUY
$25.7 - $31.46 $1.39 Million - $1.7 Million
54,172 Added 426.89%
66,862 $1.92 Million
Q3 2024

Nov 12, 2024
BUY
$23.01 - $28.55 $88,450 - $109,746
3,844 Added 43.45%
12,690 $355,000
Q2 2024

Aug 13, 2024
SELL
$23.21 - $27.24 $435,558 - $511,185
-18,766 Reduced 67.96%
8,846 $213,000
Q1 2024

May 13, 2024
BUY
$26.4 - $32.56 $728,956 - $899,046
27,612 New
27,612 $747,000
Q3 2023

Nov 07, 2023
SELL
$27.17 - $31.97 $390,758 - $459,792
-14,382 Reduced 56.02%
11,293 $316,000
Q2 2023

Aug 11, 2023
BUY
$28.34 - $33.63 $727,629 - $863,450
25,675 New
25,675 $803,000
Q4 2022

Feb 07, 2023
SELL
$21.94 - $26.24 $1.16 Million - $1.39 Million
-53,048 Reduced 71.18%
21,481 $561,000
Q3 2022

Nov 07, 2022
BUY
$22.0 - $31.87 $1.34 Million - $1.94 Million
60,797 Added 442.74%
74,529 $1.66 Million
Q2 2022

Aug 12, 2022
BUY
$26.4 - $30.54 $362,524 - $419,375
13,732 New
13,732 $409,000
Q1 2022

May 10, 2022
SELL
$23.07 - $27.99 $231,022 - $280,291
-10,014 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$21.47 - $32.08 $215,000 - $321,249
10,014 New
10,014 $233,000
Q1 2021

May 17, 2021
SELL
$18.21 - $23.2 $216,371 - $275,662
-11,882 Closed
0 $0
Q4 2020

Feb 08, 2021
BUY
$15.39 - $22.1 $182,863 - $262,592
11,882 New
11,882 $237,000
Q1 2020

May 08, 2020
SELL
$13.06 - $21.24 $138,540 - $225,313
-10,608 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$17.29 - $21.74 $85,862 - $107,960
-4,966 Reduced 31.89%
10,608 $216,000
Q3 2019

Oct 15, 2019
BUY
$19.51 - $24.28 $303,848 - $378,136
15,574 New
15,574 $304,000
Q1 2019

Oct 17, 2019
SELL
$28.4 - $36.49 $502,850 - $646,091
-17,706 Closed
0 $0
Q4 2018

Jan 15, 2019
BUY
$27.94 - $44.61 $494,705 - $789,864
17,706 New
17,706 $523,000

Others Institutions Holding ALKS

# of Institutions
393
Shares Held
176M
Call Options Held
558K
Put Options Held
427K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.18B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email